Hyperosmolar Hyperglycemic State (HHS) - Pathophysiology

SECTION 1

Historical Context & Clinical Significance

Before the advent of insulin therapy and modern critical care, patients presenting with extreme hyperglycemia and altered consciousness faced mortality rates exceeding 50 percent. The recognition that Hyperosmolar Hyperglycemic State (HHS) represented a pathophysiologically distinct entity from diabetic ketoacidosis (DKA) took several decades to formalize. Unlike DKA, where insulin deficiency is near-absolute and ketogenesis predominates, HHS typically arises in patients with type 2 diabetes who retain enough residual insulin secretion to suppress lipolysis and ketone body formation, yet insufficient insulin action to prevent massive hepatic glucose output. Understanding the historical trajectory of HHS illuminates why the condition still carries a mortality rate of 10–20 percent in contemporary practice—substantially higher than the 1–5 percent observed in DKA—making it one of the most lethal endocrine emergencies encountered in clinical medicine.

1886 • Dreschfeld's Distinction

Julius Dreschfeld delivered one of the earliest clinical lectures describing a form of diabetic coma that occurred without the fruity, acetone-laden breath typical of ketoacidosis, suggesting the existence of a non-ketotic hyperglycemic emergency.

1957 • Sament & Schwartz Case Series

Sament and Schwartz published a landmark case series documenting patients with extreme hyperglycemia (>600 mg/dL), profound dehydration, and hyperosmolality but absent or minimal ketonuria, formally establishing the syndrome as a distinct clinical entity.

1971 • Gerich, Martin, & Recant

Gerich and colleagues elucidated the pathophysiological mechanism, demonstrating that residual insulin secretion in type 2 diabetes was sufficient to prevent ketogenesis but not to prevent hyperglycemia, clarifying the metabolic distinction between HHS and DKA.

2009 • ADA Consensus Statement

The American Diabetes Association published updated consensus guidelines standardizing diagnostic criteria for HHS—serum glucose >600 mg/dL, serum osmolality >320 mOsm/kg, and absence of significant ketoacidosis—providing a unified framework for emergency management.

2024 • Modern Integrated Protocols

Contemporary guidelines emphasize that HHS and DKA exist on a spectrum, with up to one-third of patients presenting with overlapping features. Standardized ICU protocols incorporating aggressive fluid resuscitation, insulin infusion, and electrolyte monitoring have reduced mortality, though it remains significantly elevated in elderly populations.

The central question that HHS poses for the healthcare practitioner is this: why does the same hormone—insulin—produce two dramatically different clinical syndromes depending on its residual activity? The answer lies in understanding the dose-response relationships of insulin at the level of the hepatocyte, the adipocyte, and the renal tubule, and how the interplay between osmotic diuresis, counter-regulatory hormones, and impaired renal clearance creates a self-amplifying cycle of dehydration and hyperglycemia.

SECTION 2

Core Principles & Definitions

Hyperosmolar Hyperglycemic State is defined by a triad of severe hyperglycemia (typically >600 mg/dL), hyperosmolality (effective serum osmolality >320 mOsm/kg), and profound dehydration in the absence of significant ketoacidosis (pH >7.30, bicarbonate >18 mEq/L). The pathophysiology rests on several foundational principles that distinguish it from other hyperglycemic emergencies and explain its characteristic clinical presentation.

Relative Insulin Deficiency

Unlike DKA, patients with HHS retain enough circulating insulin to suppress hepatic ketogenesis and adipose tissue lipolysis. However, the available insulin is insufficient to facilitate peripheral glucose uptake or adequately suppress hepatic gluconeogenesis, resulting in extreme hyperglycemia.

Osmotic Diuresis

When plasma glucose exceeds the renal threshold (~180 mg/dL), glucose acts as an osmotic solute in the renal tubular fluid, dragging free water and electrolytes into the urine. This establishes a vicious cycle: fluid loss concentrates plasma glucose, which drives further osmotic diuresis.

Counter-Regulatory Hormone Surge

Physiologic stress—often from infection, myocardial infarction, or stroke—triggers release of glucagon, cortisol, catecholamines, and growth hormone. These hormones collectively amplify hepatic glucose production, antagonize insulin action, and promote glycogenolysis and gluconeogenesis.

Impaired Thirst & Renal Compensations

HHS predominantly affects elderly patients with limited access to fluids, impaired thirst mechanisms, or reduced glomerular filtration rate. As dehydration progresses, declining GFR reduces the kidney's ability to excrete glucose, further escalating serum glucose levels.

Neurological Consequences of Hyperosmolality

Serum osmolality above 320 mOsm/kg causes osmotic water shifts out of neurons, producing cellular dehydration and shrinkage that manifests clinically as confusion, lethargy, focal neurological deficits, and ultimately coma—the hallmark of HHS.

✦

KEY TAKEAWAY

Think of insulin as a dimmer switch, not an on-off toggle. In DKA, the switch is virtually off—no insulin means unrestrained fat breakdown and ketone production. In HHS, the dimmer is set just high enough to keep the 'fat burning furnace' (ketogenesis) suppressed, but too low to stop the 'sugar factory' (hepatic glucose output) from overproducing. The result is extreme hyperglycemia without the acidosis of ketone accumulation, analogous to a dam that holds back one river (ketones) but lets another (glucose) flood downstream.

SECTION 3

Pathophysiology Diagram

The diagram traces the pathophysiological cascade of HHS from an initial precipitating stress through counter-regulatory hormone activation, dual mechanisms of hyperglycemia (increased hepatic output and decreased peripheral uptake), osmotic diuresis, renal failure, and ultimately the hyperosmolality that drives neurological dysfunction. Note the vicious cycle indicated at the bottom: dehydration reduces GFR, which reduces glucose excretion, which worsens hyperglycemia, which drives more osmotic diuresis.

The diagram above highlights the self-reinforcing nature of HHS. A precipitating stressor—most commonly infection (40–60% of cases), but also myocardial infarction, cerebrovascular accident, or medications such as glucocorticoids and thiazide diuretics—triggers a surge in counter-regulatory hormones. These hormones increase hepatic glucose output while simultaneously impairing peripheral glucose utilization. As blood glucose climbs beyond the renal threshold, glucose spills into the urine and acts as an osmotic solute, pulling water and electrolytes along with it. The resulting volume depletion reduces glomerular filtration rate, crippling the kidney's last-resort mechanism for glucose clearance. This creates a positive feedback loop that can drive serum glucose levels above 1,000 mg/dL and effective osmolality above 350 mOsm/kg, at which point neuronal dehydration produces the severe mental status changes characteristic of the syndrome.

SECTION 4

Quantitative Framework & Key Calculations

Several quantitative calculations are essential for the clinical assessment and management of HHS. These formulas enable the clinician to determine effective osmolality, estimate fluid deficits, calculate the corrected sodium concentration, and compute the anion gap to exclude concurrent metabolic acidosis. Mastery of these calculations is fundamental to safe patient management and understanding the severity of the metabolic derangement.

EFFECTIVE SERUM OSMOLALITY

Effective Osm = 2 × [Na⁺] + [Glucose] / 18

Where [Na⁺] is in mEq/L and [Glucose] is in mg/dL. BUN is excluded because urea distributes freely across cell membranes and does not generate an osmotic gradient. An effective osmolality >320 mOsm/kg is a diagnostic criterion for HHS. Values exceeding 340 mOsm/kg are strongly associated with coma.

CORRECTED SODIUM

Na⁺(corrected) = Na⁺(measured) + 1.6 × ([Glucose] − 100) / 100

Hyperglycemia draws intracellular water into the extracellular space, diluting measured sodium. The correction factor of 1.6 mEq/L per 100 mg/dL rise in glucose above normal accounts for this dilutional effect. A corrected sodium that is elevated confirms true hyperosmolar dehydration.

ANION GAP

AG = [Na⁺] − ([Cl⁻] + [HCO₃⁻])

Normal range is 8–12 mEq/L. In pure HHS, the anion gap is typically normal or only mildly elevated. A significantly elevated anion gap (>12 mEq/L) should prompt consideration of concurrent DKA, lactic acidosis from dehydration, or renal failure.

FREE WATER DEFICIT

FWD (L) = TBW × ([Na⁺(corrected)] / 140 − 1)

Where TBW (Total Body Water) ≈ 0.6 × body weight (kg) for men and 0.5 × body weight (kg) for women. Typical free water deficits in HHS range from 8–12 liters. This estimate guides but does not solely determine the rate of intravenous fluid replacement, which must also account for ongoing losses.

💡

Clinical Pearl

In HHS, measured serum sodium is often misleadingly low or normal due to the dilutional effect of hyperglycemia. Always calculate the corrected sodium to reveal the true state of total body water depletion. A corrected sodium >145 mEq/L indicates severe free water deficit and guides the choice of hypotonic versus isotonic fluid replacement.

SECTION 5

HHS versus DKA: Classification & Comparison

While HHS and DKA are frequently taught as distinct entities, they exist on a clinical spectrum, and understanding their differences—and overlap—is essential for accurate diagnosis and management. The table below compares the key features of each syndrome. Approximately one-third of patients present with features of both conditions, a state sometimes termed mixed HHS/DKA, underscoring the importance of a systematic laboratory-based approach rather than categorical clinical labeling.

Feature	HHS	DKA
Typical Diabetes Type	Type 2 (occasionally Type 1)	Type 1 (occasionally Type 2)
Serum Glucose	>600 mg/dL (often >1,000)	>250 mg/dL
Effective Osmolality	>320 mOsm/kg	Variable (often <320)
Arterial pH	>7.30	<7.30
Serum Bicarbonate	>18 mEq/L	<18 mEq/L
Ketones	Absent or trace	Moderate to large
Anion Gap	Normal or mildly elevated	Elevated (>12 mEq/L)
Mental Status	Stupor, coma common	Alert to drowsy
Fluid Deficit	8–12 L (100–200 mL/kg)	3–6 L (50–100 mL/kg)
Mortality	10–20%	1–5%
Primary Treatment	Aggressive fluid resuscitation first, then insulin	Insulin + fluids concurrently

Comparison of HHS and DKA diagnostic and clinical features

This spectrum diagram illustrates that HHS and DKA are not binary diagnoses but exist along a continuum. The overlap zone (center, in amber) represents the approximately one-third of patients who present with features of both syndromes, requiring simultaneous treatment of dehydration, hyperglycemia, and ketoacidosis.

SECTION 6

Worked Clinical Example

The following clinical scenario walks through the systematic evaluation of a patient presenting with suspected HHS, demonstrating how to apply the diagnostic formulas and arrive at a management plan.

ℹ

Clinical Scenario

A 72-year-old woman with a history of type 2 diabetes (managed with metformin) is brought to the emergency department from her nursing home after being found obtunded. She has had decreased oral intake for 3 days due to a urinary tract infection. Vitals: HR 118, BP 88/52, RR 18 (non-Kussmaul), Temp 38.9°C. Weight: 70 kg. Labs: Glucose 980 mg/dL, Na⁺ 132 mEq/L, K⁺ 5.1 mEq/L, Cl⁻ 98 mEq/L, HCO₃⁻ 22 mEq/L, BUN 58 mg/dL, Creatinine 2.4 mg/dL. Urinalysis: trace ketones. Arterial pH: 7.34.

Systematic Evaluation for HHS

1
Step 1 — Calculate Effective Serum Osmolality

Apply the effective osmolality formula: Effective Osm = 2 × [Na⁺] + [Glucose] / 18. Substituting: Effective Osm = 2 × 132 + 980 / 18 = 264 + 54.4 = 318.4 mOsm/kg. This value approaches but does not quite exceed the 320 mOsm/kg threshold; however, given the clinical picture, it strongly supports an HHS diagnosis, as the patient's ongoing dehydration is likely to push the osmolality higher without treatment.

Effective Osmolality ≈ 318 mOsm/kg (borderline HHS criterion)
2
Step 2 — Calculate Corrected Sodium

The measured sodium of 132 mEq/L appears low-normal, but this is dilutionally depressed by the extreme hyperglycemia. Apply the correction: Na⁺(corrected) = 132 + 1.6 × (980 − 100) / 100 = 132 + 1.6 × 8.8 = 132 + 14.08 = 146.08 mEq/L. The corrected sodium reveals significant hypernatremia, confirming severe free water deficit.

Corrected Na⁺ ≈ 146 mEq/L (confirms true dehydration)
3
Step 3 — Calculate Free Water Deficit

For a 70 kg female, TBW = 0.5 × 70 = 35 L. Free Water Deficit = 35 × (146/140 − 1) = 35 × 0.043 = 1.5 L based on corrected sodium alone. However, this formula underestimates total fluid losses in HHS. Clinical estimates suggest total body fluid deficits of 100–200 mL/kg in HHS, yielding an estimated deficit of 7–14 L for this patient. The free water deficit formula provides a minimum target; ongoing losses and clinical reassessment guide actual replacement.

Estimated total fluid deficit: 7–10 L
4
Step 4 — Calculate Anion Gap

AG = Na⁺ − (Cl⁻ + HCO₃⁻) = 132 − (98 + 22) = 132 − 120 = 12 mEq/L. The anion gap is at the upper limit of normal, consistent with HHS rather than DKA. The trace ketones on urinalysis and pH of 7.34 further support the absence of significant ketoacidosis.

AG = 12 mEq/L (normal range; no significant ketoacidosis)
5
Step 5 — Synthesize Diagnosis & Initiate Management

This patient meets criteria for HHS: glucose >600 mg/dL (980), effective osmolality approaching 320 mOsm/kg with severe clinical dehydration, pH >7.30, HCO₃⁻ >18, absent significant ketosis, and altered mental status. The precipitating factor is the urinary tract infection. Management priorities in order: (1) Initiate aggressive isotonic saline (0.9% NaCl) at 1–1.5 L/hour for the first 1–2 hours to restore intravascular volume. (2) Once hemodynamically stable, transition to 0.45% NaCl at 250–500 mL/hr given the elevated corrected sodium. (3) Begin low-dose insulin infusion (0.1 U/kg/hr) only after initial fluid resuscitation has begun and potassium is confirmed >3.3 mEq/L. (4) Treat the UTI with appropriate antibiotics. (5) Monitor glucose, electrolytes, and osmolality every 1–2 hours.

Diagnosis: HHS precipitated by UTI. Priority: Fluid resuscitation → Insulin → Treat underlying cause.

SECTION 7

Management Principles & Complications

The management of HHS is centered on four pillars: aggressive fluid resuscitation, careful insulin administration, electrolyte repletion, and identification and treatment of the precipitating cause. The therapeutic approach differs from DKA in several critical respects, most notably the primacy of fluid replacement over insulin therapy and the risk of complications related to overly rapid osmolality correction.

Management Component	Rationale / Details
Fluid Resuscitation	Begin with 0.9% NaCl at 1–1.5 L/hr for 1–2 hours. Once hemodynamically stable, switch to 0.45% NaCl if corrected Na⁺ is normal or elevated, or continue 0.9% NaCl if corrected Na⁺ is low. Add dextrose 5% when glucose falls to 250–300 mg/dL. Goal: replace 50% of deficit in first 12 hours, remainder over next 24–36 hours.
Insulin Therapy	Begin insulin only AFTER initial fluid resuscitation (1–2 L). Use continuous IV insulin at 0.1 U/kg/hr or 0.14 U/kg/hr without bolus. Goal: reduce glucose by 50–75 mg/dL per hour. Premature insulin without adequate fluids can precipitate cardiovascular collapse as glucose-driven osmotic pressure drops.
Potassium Repletion	Despite often normal or elevated initial K⁺, total body potassium is depleted from osmotic diuresis. Insulin drives K⁺ intracellularly, risking fatal hypokalemia. If K⁺ <3.3 mEq/L: hold insulin, replace K⁺ first. If K⁺ 3.3–5.3: add 20–40 mEq KCl per liter of IV fluid. If K⁺ >5.3: recheck in 2 hours.
Treat Precipitant	Identify and treat the underlying cause: infection (most common—40–60%), MI, stroke, medications (glucocorticoids, thiazides, atypical antipsychotics), or new diabetes diagnosis. Without treating the precipitant, HHS will recur or fail to resolve.
Monitoring	Check glucose every 1 hour, BMP every 2–4 hours. Monitor effective osmolality—target decrease of 3–8 mOsm/kg/hr to avoid cerebral edema. Track urine output (goal >0.5 mL/kg/hr). Assess mental status frequently; it should improve as osmolality normalizes.

Summary of HHS Management Pillars

✦

KEY TAKEAWAY

Think of the HHS patient as a dried-out sponge that has been coated with concentrated sugar syrup. Your first job is to rehydrate the sponge (aggressive IV fluids), not to scrub off the sugar (insulin). If you try to remove the sugar without first rehydrating the sponge, it crumbles—analogous to cardiovascular collapse from intravascular volume loss when insulin rapidly shifts glucose intracellularly without adequate fluid replacement. The sequence matters: fluids first, insulin second, and always with an eye on potassium, which silently depletes as insulin pushes it into cells.

⚠

Potential Complications of Treatment

Overly aggressive correction carries its own dangers. Cerebral edema can occur if osmolality drops too rapidly (>3–8 mOsm/kg/hr), as neurons that have accumulated idiogenic osmoles to protect against dehydration now swell osmotically when extracellular tonicity falls. Hypokalemia from insulin-driven intracellular potassium shifts can cause fatal arrhythmias. Pulmonary edema can result from overly rapid fluid administration, especially in elderly patients with compromised cardiac function. Venous thromboembolism is common due to hemoconcentration and immobility, warranting prophylactic anticoagulation.

SECTION 8

Connections to Advanced Endocrine Pathophysiology

HHS does not exist in isolation but connects to several advanced topics in endocrine and metabolic pathophysiology. Understanding these connections deepens clinical reasoning and prepares learners for the complexity of real-world patient management, where multiple pathophysiological processes often coexist and interact.

Concept in HHS	Advanced Connection
Insulin dose-response threshold	The concept that different metabolic pathways require different concentrations of insulin to be suppressed connects directly to advanced pharmacokinetics and the receptor biology of the insulin signaling cascade (IRS-1/PI3K/Akt pathway vs. Ras/MAPK pathway).
Osmotic physiology	The Starling forces governing fluid shifts in HHS extend to understanding nephrotic syndrome, SIADH, and diabetes insipidus. Effective vs. measured osmolality is a concept with broad applications across nephrology.
Counter-regulatory hormones	The HPA axis activation in HHS parallels the stress response in critical illness, sepsis, and adrenal crisis. Understanding how cortisol and catecholamines antagonize insulin action is foundational for critical care medicine.
Neurological sequelae	Idiogenic osmoles (organic osmolytes) accumulated by neurons during chronic hyperosmolality connect to osmotic demyelination syndrome seen with overly rapid sodium correction—a principle that directly informs the caution against rapid osmolality correction in HHS.
Thrombotic risk	The hypercoagulable state in HHS—driven by hemoconcentration, endothelial dysfunction, and increased clotting factors—connects to Virchow's triad and the broader field of coagulation pathophysiology in critical illness.

Connections between HHS concepts and advanced pathophysiological topics

As learners advance into clinical rotations and critical care medicine, the principles embedded in HHS pathophysiology—dose-dependent hormone effects, osmotic fluid dynamics, self-amplifying pathological cycles, and iatrogenic risks of treatment—will recur across numerous clinical contexts. The study of HHS provides an excellent foundational framework for understanding how metabolic crises develop, propagate, and are managed in the intensive care setting.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain why patients with HHS typically do not develop significant ketoacidosis, despite having severe hyperglycemia. How does this relate to the concept of insulin dose-response thresholds at different tissues?

Show answer

In HHS, patients retain sufficient residual insulin secretion (characteristic of type 2 diabetes) to suppress lipolysis in adipose tissue and ketogenesis in the liver, because the insulin concentration required to inhibit hormone-sensitive lipase and suppress hepatic ketone body production is substantially lower than the concentration needed to stimulate peripheral glucose uptake or fully suppress hepatic gluconeogenesis. In other words, the anti-lipolytic effect of insulin has a lower dose-response threshold than the glucose-lowering effect. This means that even a small amount of circulating insulin can prevent the unrestrained free fatty acid release and beta-oxidation that drives ketoacid production in DKA, while being insufficient to prevent the severe hyperglycemia that characterizes HHS.

Question 2: BASIC CALCULATION

A patient presents with the following labs: Na⁺ 128 mEq/L, glucose 1,100 mg/dL. Calculate the effective serum osmolality and the corrected sodium. Does this patient meet osmolality criteria for HHS?

Show answer

Effective Osmolality = 2 × [Na⁺] + [Glucose]/18 = 2 × 128 + 1,100/18 = 256 + 61.1 = 317.1 mOsm/kg. Corrected Na⁺ = 128 + 1.6 × (1,100 − 100)/100 = 128 + 1.6 × 10 = 128 + 16 = 144 mEq/L. The effective osmolality of 317 mOsm/kg is just below the 320 threshold, but the corrected sodium of 144 mEq/L reveals significant dehydration masked by the dilutional hyponatremia. In clinical practice, this patient would be treated as HHS given the extreme hyperglycemia, corrected sodium, and the clinical context. The borderline osmolality would likely exceed 320 once measured sodium rises with fluid resuscitation, as glucose dilution resolves.

Question 3: INTERMEDIATE

A 68-year-old man (80 kg) with HHS has the following labs: Na⁺ 148 mEq/L, glucose 850 mg/dL, Cl⁻ 108 mEq/L, HCO₃⁻ 20 mEq/L. Calculate: (a) the corrected sodium, (b) the effective osmolality, (c) the anion gap, and (d) the estimated free water deficit. Based on these calculations, would you choose 0.9% or 0.45% NaCl as your initial resuscitation fluid, and why?

Show answer

(a) Corrected Na⁺ = 148 + 1.6 × (850 − 100)/100 = 148 + 12 = 160 mEq/L. (b) Effective Osm = 2 × 148 + 850/18 = 296 + 47.2 = 343.2 mOsm/kg. (c) AG = 148 − (108 + 20) = 20 mEq/L—mildly elevated, which may reflect lactic acidosis from dehydration or prerenal azotemia, warranting monitoring but not necessarily indicating DKA. (d) TBW = 0.6 × 80 = 48 L; FWD = 48 × (160/140 − 1) = 48 × 0.143 = 6.9 L (minimum estimate; clinical deficit likely 8–16 L). Given the severely elevated corrected sodium of 160 mEq/L and osmolality of 343, the patient is severely dehydrated. However, the initial choice should still be 0.9% NaCl to restore intravascular volume and blood pressure (the patient is likely hypotensive). Once hemodynamically stable (MAP >65, adequate urine output), transition to 0.45% NaCl to provide free water and gradually correct the hypernatremia and hyperosmolality at a safe rate.

Question 4: APPLIED

You are managing the patient from Problem 3. After 3 hours of treatment with IV fluids and insulin, repeat labs show: glucose 650 mg/dL, Na⁺ 152 mEq/L, K⁺ 3.2 mEq/L, effective osmolality 328 mOsm/kg. The patient's mental status has not improved. Identify all concerns in this clinical picture and describe the immediate adjustments you would make to the management plan.

Show answer

Several concerns are present. First, the potassium of 3.2 mEq/L is critically low (<3.3 mEq/L). Insulin must be held immediately and aggressive potassium replacement initiated (40 mEq KCl IV per hour via central line with cardiac monitoring) before restarting insulin, as hypokalemia can cause fatal cardiac arrhythmias. Second, the measured Na⁺ has risen to 152, and the corrected Na⁺ = 152 + 1.6 × (650−100)/100 = 152 + 8.8 = 160.8 mEq/L—still severely elevated—confirming that free water replacement is insufficient. The IV fluid should be transitioned to 0.45% NaCl if not already done. Third, the osmolality has decreased from 343 to 328 over 3 hours, a rate of 5 mOsm/kg/hr, which is within the acceptable range (3–8 mOsm/kg/hr), so the rate of correction is appropriate. Fourth, the lack of mental status improvement despite falling osmolality should raise concern for an alternative or concurrent neurological process (stroke, infection-related encephalopathy), warranting consideration of CT head and continued neurological assessment. The glucose decline of 67 mg/dL/hr is appropriate (goal 50–75 mg/dL/hr).

Question 5: CRITICAL THINKING

A 45-year-old woman with no known medical history is brought to the ED with glucose of 920 mg/dL, pH 7.18, HCO₃⁻ 10 mEq/L, effective osmolality of 335 mOsm/kg, and large serum ketones. Her measured Na⁺ is 126 mEq/L. She is obtunded. Analyze whether this patient has HHS, DKA, or a mixed presentation. Discuss how the management priorities differ from a 'pure' HHS case, and explain why the measured sodium is misleading. What additional workup would you pursue to determine the underlying etiology?

Show answer

This patient has a mixed HHS/DKA presentation: glucose >600 mg/dL and effective osmolality >320 mOsm/kg meet HHS criteria, while pH <7.30, HCO₃⁻ <18, and large ketones meet DKA criteria. The corrected sodium = 126 + 1.6 × (920−100)/100 = 126 + 13.1 = 139.1 mEq/L, revealing that the measured hyponatremia is entirely dilutional from the extreme hyperglycemia; the true sodium is normal, indicating that while the patient is dehydrated from osmotic diuresis, the free water deficit may be less severe than in a patient with corrected hypernatremia. Management differs from pure HHS in that insulin assumes co-equal priority with fluid resuscitation, given the life-threatening ketoacidosis (pH 7.18). A bolus of 0.1 U/kg IV insulin followed by continuous infusion at 0.14 U/kg/hr should begin simultaneously with aggressive isotonic fluid resuscitation. Potassium must be checked and replaced aggressively, as the acidosis causes extracellular potassium shift, and insulin plus acidosis correction will drive potassium intracellularly rapidly. The rate of osmolality correction must be carefully monitored given the altered mental status and the risk of cerebral edema. Additional workup should include: HbA1c (to distinguish new-onset vs. known diabetes), C-peptide and insulin levels (to assess residual beta-cell function), GAD-65 and IA-2 antibodies (to evaluate for latent autoimmune diabetes in adults/LADA), lipase (pancreatitis as precipitant), blood cultures and chest X-ray (infection screen), and troponin (MI as precipitant). The young age and mixed presentation raise the possibility of type 1 diabetes presenting with HHS features due to prolonged undiagnosed hyperglycemia, or latent autoimmune diabetes.

SUMMARY

Lesson Summary

Summary

Hyperosmolar Hyperglycemic State (HHS) is a life-threatening diabetic emergency characterized by severe hyperglycemia (>600 mg/dL), hyperosmolality (>320 mOsm/kg), and profound dehydration in the absence of significant ketoacidosis. The pathophysiology hinges on relative insulin deficiency—enough insulin to suppress ketogenesis but not enough to prevent hepatic glucose overproduction—combined with a counter-regulatory hormone surge triggered by a precipitating stressor, most commonly infection. The resulting osmotic diuresis creates a self-amplifying cycle of dehydration, declining GFR, impaired glucose excretion, and worsening hyperglycemia.

Key diagnostic calculations include effective serum osmolality, corrected sodium (to unmask true dehydration hidden by dilutional hyponatremia), anion gap (to exclude concurrent DKA), and free water deficit. Management follows a strict priority sequence: aggressive fluid resuscitation first, then insulin infusion (only after potassium is confirmed >3.3 mEq/L), electrolyte repletion, and treatment of the precipitating cause. HHS and DKA exist on a spectrum, with approximately one-third of patients presenting with mixed features requiring simultaneous management of both syndromes.